Amadeus injects £1.5m into HealX

Also taking part in the round was Jonathan Milner, the co-founder and deputy chairperson of biotech company Abcam and a non-executive director at equity crowdfunding business Syndicate Room.

The fresh capital will enable HealX to invest in research and in developing its technology platform, which matches potential treatments to rare conditions.

The transaction marks the third deal in quick succession for Amadeus. In September, the VC joined Passion Capital and Infocomm Investments in a £1.5m seed round for artificial intelligence startup Prowler.io and took part in a £2m round for automated customer service company ContactEngine alongside Beringea.

Company
Founded in 2014, Cambridge-headquartered HealX uses data analytics to investigate possible alternative uses for existing drugs, with the aim of finding cures for rare diseases.

People
Amadeus Capital Partners – Hermann Hauser (partner, co-founder).
HealX – Tim Guilliams (chief executive).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Early-stage
• UK / Ireland
• Technology
• United Kingdom
• Amadeus Capital
• Venture